Method Development and Transfer

Synthetic Chemistry
To assist in quantitative bioanalysis, our chemical synthesis group can produce non-labeled or stable isotype-labeled compounds, such as deuterated or carbon-13 analogues, for use as internal standards. We can also assist with metabolite identification, profiling and synthesis.

Method Development and Transfer
Dedicated method development teams are able to rapidly evaluate and develop assays for you. Our firsthand knowledge in the development of a wide range of compounds and our experience across the drug development continuum can be used to help you create an efficient, cost-effective and successful program from discovery through the clinical phase. Our experts provide services for method transfer, development and validation in accordance with Good Laboratory Practices (GLP).

You may also be interested in...

Vials of blood

The Murky Waters of Method Validation

This blog post focuses on the issues behind preclinical study validation and the latest recommendations for improved clarity, including a discussion of tiered approaches.

Bioactivity Assays

View this webinar replay to learn more about available assays, best practices in method development and which assays may be best for your program.

Webinar Replay

Developing fit-for-purpose large molecule assays is critical, yet challenging. We’ll discuss the pros and cons of various methods.